Skip to main content
. 2020 Oct 28;13(12):2635–2652. doi: 10.1016/j.jcmg.2020.10.005

Table 2.

Indications: Consider Addition of CMR to the Evaluation of Athletes Post–COVID-19

  • Limiting symptoms (e.g., chest pain, dyspnea, exertional intolerance, syncopal event concerning for arrhythmia) without alternative explanation, even if normal TTE

  • A sustained troponin elevation of 2 samples >99th percentile

  • New or evolving ECG changes such as diffuse ST-segment elevations or new T-wave inversions

  • ECG evidence of complex ectopic beats or ventricular arrhythmias

  • Regional LV wall motion abnormality on echocardiography

  • Global ventricular dysfunction (LVEF <50%) on echocardiography

  • Segmental RV abnormalities, significant dilation, or dysfunction on echocardiography

  • Diastolic dysfunction or abnormal strain, particularly if associated with other concerning features or new compared with prior recent imaging

  • More than trivial pericardial effusion

CMR = cardiac magnetic resonance; ECG = electrocardiogram; TTE = transthoracic echocardiogram; other abbreviations as in Table 1.